Barcelona <scp>Bio‐HF</scp> calculator version 3.0: recalibration and incorporation of sodium–glucose cotransporter 2 inhibitor treatment-Reference-Cited by-同舟云学术

Barcelona Bio‐HF calculator version 3.0: recalibration and incorporation of sodium–glucose cotransporter 2 inhibitor treatment

Published:2022-12-20 Issue:1 Volume:25 Page:131-132
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Codina Pau¹²,Lupón Josep¹²³,Subirana Isaac³⁴,Zamora Elisabet¹²³,Domingo Mar¹,Santiago‐Vacas Evelyn¹,Cediel Germán¹,Borrellas Andrea¹,Barallat Jaume⁵,Bayes‐Genis Antoni¹²³^ORCID

Affiliation:

1. Heart Failure Unit Hospital Universitari Germans Trias i Pujol Badalona Spain

2. Department of Medicine Autonomous University of Barcelona Barcelona Spain

3. CIBERCV, Instituto de Salud Carlos III Madrid Spain

4. IMIM (Hospital del Mar Medical Research Institute) Barcelona Spain

5. Biochemistry Service Hospital Universitari Germans Trias i Pujol Badalona Spain

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2752

Reference5 articles.

1. Head‐to‐head comparison of contemporary heart failure risk scores

2. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

3. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

4. Development of a Novel Heart Failure Risk Tool: The Barcelona Bio-Heart Failure Risk Calculator (BCN Bio-HF Calculator)

5. Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Barcelona Bio-Heart Failure Risk Calculator may predict one-year mortality in patients with advanced heart failure;Polish Archives of Internal Medicine;2024-04-24

2. Heart failure risk scores in advanced heart failure patients: insights from the LEVO‐D registry;ESC Heart Failure;2023-07-08

3. Reply to ‘The frail patient and the frailing heart’;European Journal of Heart Failure;2023-02-26

4. The frail patient and the frailing heart. Letter regarding the article ‘Barcelona Bio‐HF calculator version 3.0: recalibration and incorporation of sodium–glucose cotransporter 2 inhibitor treatment’;European Journal of Heart Failure;2023-02-02